CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CONMED Corporation

CONMED Corporation is a global medical technology company that designs and manufactures surgical devices and equipment.

msh id	COM:CONMED
symbol	CNMD
name	CONMED Corporation
homepage url	https://www.conmed.com
country	US
sector	Healthcare
industry	Medical - Devices
market	STOCKS
employee count	4K
crunchbase url	-
linkedin url	-
founders	-

market cap	2.01B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.14
growth cost of revenue	0.26
growth depreciation and amortization	1.46
growth ebitda	5.34
growth ebitda ratio	4.66
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	0.13
growth gross profit ratio	-0.05

COM:CONMED

CONMED Corporation

Last Close

70.69

21/11 19:39

Market Cap

2.01B

Beta: -

Volume Today

150.27K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	1.11B
cost of revenue	1.11B
depreciation and amortization	51.4M
ebitda	182.19M
ebitda ratio	0.15
eps	2.1
eps diluted	2.04
operating expenses	512.28M
operating income	130.79M
operating income ratio	0.11

accounts receivables	-47.07M
capital expenditure	-19.03M
cash at beginning of period	28.94M
cash at end of period	24.3M
inventory	318.32M
working capital ttm	249.33M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-